Highly abundant neutral core HMO
LNT (Lacto-N-Tetraose) is a highly abundant neutral core HMO in human milk. Some primary known benefits of LNT include reducing infection by inhibiting the adhesion of pathogenic bacteria and their toxins. Also, LNT can positively support gut health by selectively stimulating bifidobacteria.
Regulatory filings for LNT have been made in EU and US and preparation is on way for other major markets.
GlyCare™ LNT will be commercially available from 2020.